Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)

Summary

Umbilical Cord-derived Mesenchymal stem cell has been proven effective in the experimental bronchopulmonary dysplasia (BPD).A multi-center study was designed to evaluate the safety and efficacy of the cellular therapy in extremely preterm infants at high risk for BPD.

Timeline

Start

2019-12-01

Primary completion

2022-10-30

Completion

2023-04-01

Outcome

Outcome not reported

Stopped: “The certification of cell-based treatment in the settings need to be updated.”

Drugs

Indications